{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:24:43Z","timestamp":1777613083687,"version":"3.51.4"},"reference-count":46,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T00:00:00Z","timestamp":1321833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ulcerative colitis (UC) is an immune disorder of the gastrointestinal tract which has been reported to be precipitated by interferon (IFN) therapy. We describe the results of a literature review of cases in which the development or exacerbation of UC was coincident with IFN and\/or ribavirin (RIB) treatment for chronic hepatitis C. We summarized the studies on the effectiveness of IFN for UC or Crohn's disease, which were primarily carried out in Europe and the USA.<\/jats:p><jats:p>In the nine reported cases of UC exacerbation by IFN therapy in Japan, seven involved IFN\u2010\u03b1, one involved IFN\u2010\u03b12b plus RIB, and the other involved IFN\u2010\u03b2; thus cases induced by IFN\u2010\u03b1 were more common. The period between the initiation of IFN treatment and the development or exacerbation of UC varied widely among the reported cases (from 1\u2003day to 4.5\u2003years). The reports have all assumed a cause\u2010and\u2010effect correlation between IFN treatment and UC. However, although combination therapy of IFN and RIB has become widespread in Japan, UC development or exacerbation induced by IFN has not increased concurrently.<\/jats:p><jats:p>Conversely, numerous studies reporting the effectiveness of IFN for treating UC and Crohn's disease have been published in Europe and the USA. One reason for this finding may be the difference in the balance of T helper cell 1 and T helper cell 2 between populations.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2011.06890.x","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T19:48:12Z","timestamp":1314820092000},"page":"1709-1716","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Literature review in cases with exacerbation of ulcerative colitis induced by treatment with interferon and\/or ribavirin"],"prefix":"10.1111","volume":"26","author":[{"given":"Takuya","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Hirono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Soga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,11,21]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"55","article-title":"Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view","volume":"51","author":"Pellicano R","year":"2005","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.32.327"},{"key":"e_1_2_5_4_2","first-page":"1085","article-title":"A case of incidence of ulcerative colitis during the therapy of interferon for hepatitis C","volume":"90","author":"Honda K","year":"1993","journal-title":"Nippon Shokakibyo Gakkai Zasshi (JJSG)"},{"key":"e_1_2_5_5_2","first-page":"1066","article-title":"A case of chronic hepatitis B with exacerbation of ulcerative colitis and acute worsening on chronic hepatitis induced by the therapy of interferon","volume":"92","author":"Yasumori K","year":"1995","journal-title":"Nippon Shokakibyo Gakkai Zasshi (JJSG)"},{"key":"e_1_2_5_6_2","first-page":"1293","article-title":"Interferon induced IBD\u2010like acute colitis: two cases of patients with chronic active hepatitis","volume":"92","author":"Yamamoto Y","year":"1995","journal-title":"Nippon Shokakibyo Gakkai Zasshi (JJSG)"},{"key":"e_1_2_5_7_2","first-page":"54","article-title":"Interferon induced ulcerative colitis\u2010like acute colitis","volume":"53","author":"Usami T","year":"1999","journal-title":"Rinsho-hinyokika"},{"key":"e_1_2_5_8_2","first-page":"399","article-title":"A case of ulcerative colitis along with characteristic features on computed tomography (CT), developed by the treatment with interferon for chronic hepatitis C","volume":"98","author":"Niki T","year":"2001","journal-title":"Nippon Shokakibyo Gakkai Zasshi (JJSG)"},{"key":"e_1_2_5_9_2","first-page":"3286","article-title":"A case of ulcerative colitis developed during the interferon therapy after the operation of renal cell carcinoma","volume":"83","author":"Inoue F","year":"2001","journal-title":"Chiryo"},{"key":"e_1_2_5_10_2","first-page":"680","article-title":"A case of acute phase ulcerative colitis like colitis developed by the interferon\u2010beta therapy for chronic hepatitis C","volume":"100","author":"Awakawa T","year":"2003","journal-title":"Nippon Shokakibyo Gakkai Zasshi (JJSG)"},{"key":"e_1_2_5_11_2","first-page":"1061","article-title":"A case of exacerbation of ulcerative colitis induced by combination therapy with PEG\u2010interferon alpha\u20102b and ribavirin for chronic hepatitis C","volume":"103","author":"Watanabe T","year":"2006","journal-title":"Nippon Shokakibyo Gakkai Zasshi (JJSG)"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00022-8"},{"key":"e_1_2_5_13_2","first-page":"438","article-title":"Acute ulcerative colitis during successful interferon\/ribavirin treatment for chronic hepatitis","volume":"54","author":"Sprenger R","year":"2005","journal-title":"Gut"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.105197"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20152"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i26.3638"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.120"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21242"},{"key":"e_1_2_5_19_2","first-page":"597","article-title":"Induction of remission by interferon\u2010alpha in patients with chronic active ulcerative colitis","volume":"7","author":"S\u00fcmer N","year":"1995","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"e_1_2_5_20_2","first-page":"3","article-title":"Clinical course of inflammatory bowel disease during treatment with interferon for associated chronic active hepatitis","volume":"27","author":"Cottone M","year":"1995","journal-title":"Ital. J. Gastroenterol."},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03875.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.9.1286"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.12.1728"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02556.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-963378"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.2169\/naika.82.656"},{"key":"e_1_2_5_27_2","unstructured":"MSD.Adverse reactions and notandums. A combination therapy of PEG\u2010Interferon and Ribavirin. Cited 21 March 2011. Available from URL:http:\/\/www.c\u2010kan.net\/hepatitis\u2010c\/peg\u2010ifn\/0301.html(In Japanese)."},{"key":"e_1_2_5_28_2","first-page":"132","article-title":"Interferon\u2010alpha induced and ribavirin induced thyroid dysfunction in patients with chronic hepatitis C","volume":"10","author":"Nadeem A","year":"2010","journal-title":"J. Hepat. Mon."},{"key":"e_1_2_5_29_2","unstructured":"Incurable Disease Information Center.Ulcerative Colitis\u2014Specified Diseases. Cited 21 March 2011. Available from URL:http:\/\/www.nanbyou.or.jp\/sikkan\/009.htm. (In Japanese)."},{"key":"e_1_2_5_30_2","first-page":"1","article-title":"Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991","volume":"8","author":"Morita N","year":"1995","journal-title":"J. Gastroenterol."},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0057-3"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.226860"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016967"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20406"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.2957\/kanzo.44.309"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.157.3.1261"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240102"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(01)00393-9"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2007.09.014"},{"key":"e_1_2_5_40_2","first-page":"1362","article-title":"A case study: interferon\u2010beta\u2010induced remission of ulcerative colitis in a patient with type C chronic hepatitis","volume":"105","author":"Miike T","year":"2008","journal-title":"Nippon Shokakibyo Gakkai Zasshi (JJSG)"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1159\/000112654"},{"key":"e_1_2_5_42_2","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.4049\/jimmunol.160.7.3487","article-title":"Ribavirin inhibits viral\u2010induced macrophage production of TNF, IL\u20101, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response","volume":"160","author":"Ning Q","year":"1998","journal-title":"J. Immunol."},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1089\/105072503322238809"},{"key":"e_1_2_5_44_2","first-page":"1211","article-title":"Thyroid dysfunctions in patients with viral hepatitis treated with interferon\u2010alpha","volume":"145","author":"F\u00f6ldes I","year":"2004","journal-title":"Orv. Hetil."},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1460743"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.03.001"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1992.tb05836.x"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2011.06890.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2011.06890.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T22:44:48Z","timestamp":1697323488000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2011.06890.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,21]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["10.1111\/j.1440-1746.2011.06890.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06890.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,21]]},"assertion":[{"value":"2011-11-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}